EP3468957
KRISTALLSKENND ÚTGÁFA AF (R)-4-(5-(SÝKLÓPRÓPÝLETÝNÝL)ÍSOXASÓL-3-ÝL)-N-HÝDROXÝ-2-METÝL-2-(METÝLSÚLFÓNÝL)BÚTANAMÍÐI SEM BAKTERÍULYF
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
12.6.2017EP published:
26.8.2020EP application number:
17739696.7
EP translation filed:
18.9.2020Grant published:
15.10.2020EPO information:
European Patent Register
Max expiry date:
11.6.2037Expiry date:
11.6.2022
Title:
CRYSTALLINE FORM OF (R)-4-(5-(CYCLOPROPYLETHYNYL)ISOXAZOL-3-YL)-N-HYDROXY-2-METHYL-2-(METHYLSULFONYL)BUTANAMIDE AS AN ANTIBACTERIAL AGENT
Timeline
Today
12.6.2017EP application
26.8.2020EP Publication
18.9.2020Translation submitted
15.10.2020Registration published
11.6.2022Expires
Owner
Name:
NOVARTIS AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
FU, JipingAddress:
Emeryville, California 94608, US
Name:
JIANG, SiyiAddress:
Shanghai 201203, CN
Name:
KORDIKOWSKI, AndreasAddress:
CH-4002 Basel, CH
Name:
SWEENEY, Zachary KevinAddress:
Redwood City, California 94602, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
PCT/CN2016/085694Date:
14.6.2016Country:
WO
Classification
Categories:
C07D 261/08, A61K 31/42, A61P 31/04
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 10.6.2021
Expires: 11.6.2022
Payer: G.H. Sigurgeirsson ehf.